Verana Health Continues to Strengthen Leadership Team With Several Hires

Verana Health appoints Marie-Eve Piche as Chief Financial Officer,
Hylton Kalvaria as Vice President of Strategic Partnerships, Karim Damji
as Head of Product, and Ron Cantrell as Senior Director and Principal
Data Scientist

SAN FRANCISCO–(BUSINESS WIRE)–Verana
Health
, the technology company assembling the largest clinical
databases in medicine to accelerate research, today announced four key
additions to its leadership team: Marie-Eve Piche as Chief Financial
Officer, Hylton Kalvaria as Vice President of Strategic Partnerships,
Karim Damji as Head of Product, and Ron Cantrell as Senior Director and
Principal Data Scientist. The company continues to source exceptional
individuals from the strongest organizations in healthcare and
technology. Piche, Kalvaria, Damji and Cantrell bring significant
experience to the Verana Health team to aid the company’s strategic
expansion.

  • Piche has nearly two decades of finance experience and spent
    over 10 years in key financial roles at major subsidiaries of General
    Electric. After GE she moved to scaling rapidly-growing technology
    companies such as Pymetrics and AppNexus, where she helped grow
    revenue by more than six times over the course of her tenure and
    served as part of the team that drove the $1.6B acquisition of
    AppNexus by AT&T.
  • Kalvaria joins Verana from Flatiron Health, where he founded,
    built and led the West Coast business, representing half of Flatiron’s
    commercial activity. Kalvaria previously held a variety of roles at
    Genentech and was appointed to lead a CEO-sponsored initiative focused
    on identifying emerging sources of real world data and utilizing those
    data across the Genentech organization. That initiative led to Roche’s
    initial investment in Flatiron.
  • Damji brings decades of product leadership experience to
    Verana. He most recently led product at Saama, where he launched
    solutions for the life science industry including the award-winning
    Life Science Analytics Cloud (LSAC), named one of PM360’s Most
    Innovative Products of 2017. LSAC was the impetus for Frost &
    Sullivan’s recognition of Saama with its 2018 Global Enabling
    Technology Leadership Award.
  • Cantrell has over a decade of experience working with and
    analyzing real world data in the life science industry. He previously
    served as Principal Data Scientist at Genentech, where he led real
    world evidence generation across the company’s Ophthalmology
    portfolio, working with cross-functional teams to apply scientific
    expertise to real world data. He started his life science career as a
    methodologist at Eli Lilly.

“Marie-Eve, Hylton, Karim and Ron add a substantial amount of scientific
expertise and leadership experience to the rapidly-expanding Verana team
that will be crucial to the continued growth and development of our
regulatory-grade specialty data platform for ophthalmology and
neurology,” said Miki Kapoor, CEO of Verana Health. “With the addition
of these healthcare and technology experts, Verana is poised to
meaningfully accelerate the rate of medical research for patients,
physicians and the entire healthcare ecosystem.”

The additions of Piche, Kalvaria, Damji and Cantrell are a testament to
the company’s exponential growth; in the past year, Verana Health hired
half a dozen senior leaders from high profile health data and life
science companies, including Medidata Solutions, IQVIA, Oracle, Emdeon,
and Flatiron Health. Last April, Miki Kapoor was brought on as the
company’s Chief Executive Officer, after previously serving the same
position at Tea Leaves Health and in senior executive roles at Everyday
Health and IMS Health. Other notable hires from last year include Marc
Berger (Senior Vice President and General Counsel), Ellenmarie Rhone
(Senior Vice President of People and Culture), and Don Butler (Vice
President of Life Science, Commercial).

In the coming months, Verana Health will continue to aggressively scale
its team to develop new technologies for physicians and the life science
industry.

About Marie-Eve Piche

Marie-Eve Piche is Chief Financial Officer at Verana Health. Piche
brings nearly two decades of financial management experience in public
and fast-growing private companies to the Verana team. Prior to joining
Verana, Piche was the CFO of Pymetrics, where she built the financial
strategy and capabilities that resulted in a successful Series B
fundraising with General Atlantic. Prior to this, Piche spent five years
at AppNexus as the Vice President of Financial Planning and Analysis
where she helped grow revenue by more than six times over the course of
her tenure and served as part of the team that drove the $1.6B
acquisition by AT&T. Piche started her professional career at General
Electric where she spent 11 years holding several key financial roles.
This included Head of Finance for NBC Sports and Senior Director for
Telemundo. She was selected for the leadership program at GE Industrial
and GE Capital.

Piche received her dual MBA from Columbia University and London Business
School. She also holds a Master’s in economics from McGill University
and a B.Com. from H.E.C. Montreal.

About Hylton Kalvaria

As Vice President of Strategic Partnerships at Verana Health, Hylton
Kalvaria leads the company’s life science data science delivery and
engagement functions. Kalvaria is an industry leader in the use of real
world data to accelerate life science innovation, demonstrated over the
course of a decade in commercial leadership roles across the consulting,
life science, and technology industries. Prior to Verana, Kalvaria
founded, built and led Flatiron’s West Coast business, which represented
half of Flatiron’s commercial activity. At Flatiron, Kalvaria built
enterprise partnerships with life science customers to increase the use
of Flatiron’s clinical data across all phases of the drug development
lifecycle including commercial, clinical development, medical affairs
and outcomes research teams. In addition, he led the development and
execution of Flatiron’s clinical trials strategy and go to market
approach. Before Flatiron, he held a variety of roles at Genentech,
covering all aspects of drug commercialization and was appointed to lead
a CEO-sponsored initiative focused on identifying emerging sources of
real world data and utilizing those data across the Genentech
organization. That appointment directly led to the identification of
Flatiron as a high priority partner for the Genentech’s oncology
portfolio. Kalvaria was previously a consultant with ZS Associates and
began his career in technology.

Kalvaria holds an MBA and Bachelor’s degree in Economics from Duke
University.

About Karim Damji

Karim Damji serves as Head of Product at Verana Health, where he is
responsible for leading product strategy and development. Damji, a
product veteran with a 20 year track record of success, has launched
some of the most notable solutions in healthcare and technology. Damji
previously led the product, engineering and marketing organization at
Saama. His team was responsible for developing Saama’s AI-enabled data
analytics solutions and identifying opportunities that led to successful
market share growth. Damji worked closely with Saama’s solution
development and sales teams to expand the company’s industry footprint
and led the successful launch and adoption of Saama’s solutions in the
life science industry, including the Deep Learning Intelligent Assistant
(DaLIA) and the award-winning Life Science Analytics Cloud (LSAC). LSAC
was named one of the PM360’s Most Innovative Products of 2017 and was
the impetus for Frost & Sullivan’s recognition of Saama with its 2018
Global Enabling Technology Leadership Award. Prior to Saama, Damji led
software strategy and product management at Plantronics. He also served
in leadership positions spanning business development, product
management, sales, and network engineering at Cisco, and as founding
head of product at Vocera Communications, MobileIron and DiVitas.

Damji earned his Bachelor’s degree in computational and applied
mathematics from San Jose State University.

About Ron Cantrell, PhD, MPH

Ron Cantrell leads clinical data science at Verana as Senior Director &
Principal Data Scientist. Cantrell has over a decade of experience
working with and analyzing real world data in the life science industry.
Prior to joining Verana, Cantrell was Principal Data Scientist at
Genentech, where he led real world evidence generation across
Roche/Genentech’s Ophthalmology portfolio. In this role, he worked with
the product development and medical affairs teams to apply scientific
expertise to real world data, creating insights to enable better
development decisions for treatments that could improve patient care.
Cantrell began his career in the life science industry at Eli Lilly,
where he worked as a methodologist in the Global Health Outcomes
division, covering diabetes, immunology and neuroscience. Before Eli
Lilly, he worked with the Centre for Infectious Disease Research in
Zambia, where he served as the lead epidemiologist evaluating the
effectiveness of antiretroviral treatment for HIV patients provided
therapy through the President’s Emergency Plan for AIDS Relief.

Cantrell holds a PhD in Epidemiology and a MPH in International Health
from the University of Alabama at Birmingham, and a Bachelor’s degree in
Natural Sciences from Johns Hopkins University.

About Verana Health

Verana Health is a technology company assembling the largest clinical
databases in medicine. Verana utilizes this real world data to power
clinical and business insights for physicians and life science companies
through its regulatory-grade data platform. By activating this vast
amount of data, Verana can learn from the collective experience of
millions of patients to empower physicians and accelerate research for
patients. Learn more at veranahealth.com.

Contacts

Hallie Grossman, DKC News
hallie_grossman@dkcnews.com
(212)
981-5716

error: Content is protected !!